Export 13 results:
Author [ Keyword(Desc)] Title Year
Filters: First Letter Of Title is P and Author is Langer, Shelby L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Adult
Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JABroeckel, Dikmen S.  2011.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.. J Clin Oncol. 29(17):2397-404.
Aged
Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JABroeckel, Dikmen S.  2011.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.. J Clin Oncol. 29(17):2397-404.
Cognition Disorders
Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JABroeckel, Dikmen S.  2011.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.. J Clin Oncol. 29(17):2397-404.
Female
Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JABroeckel, Dikmen S.  2011.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.. J Clin Oncol. 29(17):2397-404.
Hematopoietic Stem Cell Transplantation
Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JABroeckel, Dikmen S.  2011.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.. J Clin Oncol. 29(17):2397-404.
Humans
Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JABroeckel, Dikmen S.  2011.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.. J Clin Oncol. 29(17):2397-404.
Male
Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JABroeckel, Dikmen S.  2011.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.. J Clin Oncol. 29(17):2397-404.
Middle Aged
Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JABroeckel, Dikmen S.  2011.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.. J Clin Oncol. 29(17):2397-404.
Neoplasms
Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JABroeckel, Dikmen S.  2011.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.. J Clin Oncol. 29(17):2397-404.
Prospective Studies
Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JABroeckel, Dikmen S.  2011.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.. J Clin Oncol. 29(17):2397-404.
Survivors
Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JABroeckel, Dikmen S.  2011.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.. J Clin Oncol. 29(17):2397-404.
Time Factors
Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JABroeckel, Dikmen S.  2011.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.. J Clin Oncol. 29(17):2397-404.
Transplantation, Homologous
Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JABroeckel, Dikmen S.  2011.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.. J Clin Oncol. 29(17):2397-404.